Открытое овальное окно и эмболический криптогенный инсульт
АА Кулеш, ВВ Шестаков - Неврология, нейропсихиатрия …, 2019 - cyberleninka.ru
В статье рассмотрена актуальная проблема криптогенного инсульта и открытого
овального окна (ООО). Освещены вопросы патогенеза и роль парадоксальной эмболии …
овального окна (ООО). Освещены вопросы патогенеза и роль парадоксальной эмболии …
Cardioembolic stroke: mechanisms and therapeutics
DC Sacchetti, KL Furie, S Yaghi - Seminars in neurology, 2017 - thieme-connect.com
Cardioembolic stroke accounts for nearly 30% of all known stroke mechanisms. This
percentage may be underestimated, however, when considering the large proportion of …
percentage may be underestimated, however, when considering the large proportion of …
Emerging risk factors for recurrent vascular events in patients with embolic stroke of undetermined source
Y Ueno, K Yamashiro, R Tanaka, T Kuroki, K Hira… - Stroke, 2016 - Am Heart Assoc
Background and Purpose—Underlying embolic causes diagnosed by transesophageal
echocardiography could be implicated in mechanisms of embolic stroke of undetermined …
echocardiography could be implicated in mechanisms of embolic stroke of undetermined …
Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis
Purpose Patients with patent foramen ovale (PFO) and cryptogenic ischemic stroke (CS) are
at risk for stroke recurrence. The optimal antithrombotic strategy in patients who undergo …
at risk for stroke recurrence. The optimal antithrombotic strategy in patients who undergo …
Percutaneous closure versus medical therapy for stroke with patent foramen Ovale: a systematic review and meta-analysis
XL Zhang, LN Kang, L Wang, B Xu - BMC cardiovascular disorders, 2018 - Springer
Background Patent foramen ovale (PFO) closure has emerged as a secondary prevention
option in patients with PFO and cryptogenic stroke. However, the comparative efficacy and …
option in patients with PFO and cryptogenic stroke. However, the comparative efficacy and …
Aspirin or anticoagulation after cryptogenic stroke with patent foramen ovale: systematic review and meta-analysis of randomized controlled trials
Introduction Since closure has restrictive eligibility criteria, the vast majority of patients with
cryptogenic stroke and patent foramen ovale (PFO) receive medical treatment. However, the …
cryptogenic stroke and patent foramen ovale (PFO) receive medical treatment. However, the …
Meta-analysis of randomized controlled trials on patent foramen ovale closure versus medical therapy for secondary prevention of cryptogenic stroke
The optimal management of patients with cryptogenic stroke (CS) and patent foramen ovale
(PFO) remains controversial. We conducted a meta-analysis to assess the effect of PFO …
(PFO) remains controversial. We conducted a meta-analysis to assess the effect of PFO …
Patent foramen ovale closure versus medical therapy after cryptogenic stroke: An updated meta-analysis of all randomized clinical trials
Background: Cryptogenic strokes can be attributed to paradoxical emboli through patent
foramen ovale (PFO). However, the effectiveness of PFO closure in preventing recurrent …
foramen ovale (PFO). However, the effectiveness of PFO closure in preventing recurrent …
Antithrombotic management of ischemic stroke
KL Sloane, EC Camargo - Current treatment options in cardiovascular …, 2019 - Springer
Purpose of review Ischemic stroke describes a condition in which inadequate blood flow
leads to lack of oxygenation to the brain tissue and ensuing neuronal death. There are …
leads to lack of oxygenation to the brain tissue and ensuing neuronal death. There are …
Patent foramen ovale closure versus medical therapy for cryptogenic stroke: meta-analysis of randomised trials
TKM Wang, MTM Wang, P Ruygrok - Heart, Lung and Circulation, 2019 - Elsevier
Background Patent foramen ovale (PFO) is a common anatomic variant associated with
cryptogenic stroke. Percutaneous PFO closure in these patients to prevent recurrent …
cryptogenic stroke. Percutaneous PFO closure in these patients to prevent recurrent …